The Clot Management Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for clot management devices has exhibited substantial growth lately. It is projected to increase from $1.72 billion in 2024 to $1.83 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%.
The forecast for the Clot Management Devices market in 2029 predicts a value of $2.32 billion, with a compound annual growth rate (CAGR) of 6.0%.
Download Your Free Sample of the 2025 Clot Management Devices Market Report and Uncover Key Trends Now!The drivers in the clot management devices market are:
• Rising aging population
• Regulatory approvals and clinical trials
• Growing awareness and screening programs
• Increasing prevalence of cardiovascular diseases
The clot management devices market covered in this report is segmented –
1) By Product Type: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) devices, Inferior vena cava filters (IVCF)
2) By Percutaneous Thrombectomy Devices Type Outlook: Aspiration Thrombectomy Devices, Percutaneous Mechanical Thrombectomy Device
3) By End User: Diagnostic centers, Hospitals
The trends in the clot management devices market are:
• Advances in technology are playing a major role in shaping the clot management devices market.
• The development of next-generation thrombectomy tools is an upcoming trend.
• Customized treatment plans are becoming increasingly widespread.
• Collaborations, partnerships, and integration of artificial intelligence and machine learning are key emerging trends.
The major players in the clot management devices market are:
• Cardinal Health Inc.
North America was the largest region in the clot management devices market in 2023